Four details:
1. The company is offering its pin-prick blood tests to U.K. employees to test for COVID-19. The tests were designed to monitor kidney and liver functions and sold directly to consumers.
2. The tests may show whether the person was exposed to COVID-19 and potential immunity. Those who do have immunity could leave their homes for work, according to the report. A company spokesperson said the tests had 99 percent specificity and 95 percent sensitivity.
3. Babylon’s employee test is voluntary and could serve as a pilot for broader roll-out. However, the requirement to report results to the company has raised privacy concerns.
4. Babylon Health has also been in the news for furloughing around 5 percent of its workforce, or about 100 staff members, in early April despite its $2 billion valuation last year.
More articles on healthcare:
Microsoft chatbot supports plasma donation from recovered COVID-19 patients
Google Cloud aims to boost health system interoperability, data analytics with API release: 5 details
Where IT leaders are spending during the pandemic: 5 things to know
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
